Publication: Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission
dc.contributor.author | ARIKAN, İZZET HAKKI | |
dc.contributor.authors | Arikan, Hakki; Koc, Mehmet; Cakalagaoglu, Fulya; Tuglular, Serhan; Ozener, Cetin; Akoglu, Emel | |
dc.date.accessioned | 2022-03-12T17:37:09Z | |
dc.date.available | 2022-03-12T17:37:09Z | |
dc.date.issued | 2009 | |
dc.description.abstract | Aim: Primary type I membranoproliferative glomerulonephritis (MPGN) is a rare cause of glomerular disease with a high relapse rate and poor prognosis. The aim of this study was: (i) to evaluate the histopathological findings associated with remission; and (ii) to document the possible clinical and histopathological factors predicting relapses. Methods: Eleven type I MPGN patients (five men, six women; mean age, 38.8 +/-13.5 years) who were in remission for at least 1 year after the cessation of immunosuppressive drugs were re-biopsied. The intensity of immunostaining for tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta 1, and tenascin was graded from 0 (no staining) to 3+ (maximum staining). Results: Mean baseline mesangial cellularity score and tubulointerstitial infiltration score were reduced and mesangial matrix expansion score was increased at protocol re-biopsies compared to baseline. The glomerular and tubulointerstitial staining scores for TGF-beta 1 and tenascin were higher than that of baseline. Reduced tubulointerstitial TNF-alpha expression was found in re-biopsy specimens compared to baseline. Patients have been followed for a mean time of 51.5 +/- 22.2 months after the protocol biopsy. Eight patients had a relapse. Mesangial cellularity score and glomerular tenascin expression at re-biopsy specimens were higher in relapsed patients compared to those without a relapse. Conclusion: Our study shows that mesangial cellularity and tubulointerstitial cell infiltration are reducing whereas mesangial matrix expansion, glomerular and tubulointerstitial TGF-beta 1 and tenascin expression are increasing with remission. The higher mesangial cell proliferation and glomerular tenascin scores in remission are associated with the development of relapse. | |
dc.identifier.doi | 10.1111/j.1440-1797.2008.01048.x | |
dc.identifier.eissn | 1440-1797 | |
dc.identifier.issn | 1320-5358 | |
dc.identifier.pubmed | 19298642 | |
dc.identifier.uri | https://hdl.handle.net/11424/229350 | |
dc.identifier.wos | WOS:000264785200012 | |
dc.language.iso | eng | |
dc.publisher | WILEY | |
dc.relation.ispartof | NEPHROLOGY | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | histopathology | |
dc.subject | primary membranoproliferative glomerulonephritis | |
dc.subject | re-biopsy | |
dc.subject | relapse | |
dc.subject | tenascin | |
dc.subject | RAT MESANGIAL CELLS | |
dc.subject | EXTRACELLULAR-MATRIX | |
dc.subject | PATHOLOGICAL CONDITIONS | |
dc.subject | EPITHELIAL-CELLS | |
dc.subject | IGA NEPHROPATHY | |
dc.subject | TNF-ALPHA | |
dc.subject | THERAPY | |
dc.subject | PROLIFERATION | |
dc.subject | CHILDREN | |
dc.title | Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | 29191abc-0649-4e18-a16c-df1be1f4ee3d | |
local.import.package | SS17 | |
local.indexed.at | WOS | |
local.indexed.at | SCOPUS | |
local.journal.numberofpages | 8 | |
oaire.citation.endPage | 226 | |
oaire.citation.issue | 2 | |
oaire.citation.startPage | 219 | |
oaire.citation.title | NEPHROLOGY | |
oaire.citation.volume | 14 | |
relation.isAuthorOfPublication | 1fe3028b-011e-403a-ac08-1932d177a065 | |
relation.isAuthorOfPublication.latestForDiscovery | 1fe3028b-011e-403a-ac08-1932d177a065 |